To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)
PHASE4CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
May 1, 2005
Primary Completion Date
April 4, 2006
Study Completion Date
April 4, 2006
Conditions
Hypercholesterolemia
Interventions
DRUG
MK0733, simvastatin / Duration of Treatment: 12 Weeks
Trial Locations (1)
106
Merck Sharp & Dohme (I.A.) Corp., Taipei
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00398294 - To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264) | Biotech Hunter | Biotech Hunter